- Diagnostics
- Friday, 05 Jun 2020
Japan to have coronavirus vaccines in use by June 2021
Drugmakers around the world are scrambling to develop a treatment or vaccine for COVID-19, the respiratory disease caused by the highly infectious new coronavirus which has so far killed nearly 400,000 people worldwide.
“We will be securing production facilities in parallel with expedited vaccine development,” Japan’s Health Minister Katsunobu Kato told reporters as he outlined plans to bring vaccines into use by the end of the first half of 2021.
Usually, plants for actual vaccine production are arranged only after the successful completion of development.
The Japanese government has earmarked 146 billion yen ($1.34 billion) for vaccine production and distribution in the second extra budget that Prime Minister Shinzo Abe’s cabinet approved last month.
Japanese pharmaceutical firms developing coronavirus vaccines include Shionogi & Co and AnGes Inc.
Related Industry Updates
Brain Aneurysm Treatment Market to Witness Rising Demand by 2020-2027 | Stryker Corporation, MicroPort Scientific Corporation, Terumo Corporation, Penumbra, Medtronic and Johnson & Johnson Services, Inc.
Sep 24, 2020
China criticizes Indian to stop using Chinese coronavirus test kits
Apr 28, 2020
Viracor Eurofins Launches Highly Accurate Antibody Tests for Coronavirus (COVID-19) SARS-CoV-2
May 08, 2020
United Global Alliance Partners With Acumen Research Laboratories to Distribute Novel Coronavirus Diagnostic Test Kits
Apr 07, 2020
Epidemic in the UK is slowing and antibody test could be ready in days, top epidemiologist says
Mar 30, 2020
Dominion Diagnostics Offering COVID-19 Serology Antibody Testing
Jun 25, 2020
Europe Foot Orthotic Insoles Market to Witness an Outstanding Growth During 2020 With Top Key Players Aetrex Worldwide, Inc,Bauerfeind AG,OttoBock,Superfeet Worldwide Inc.,Sidas,Algeos,Yellow Wood Partners, LLC
Dec 02, 2020
Follow us on
